Oxidation of terfenadine by Streptomyces platensis: Influence of culture medium on metabolite formation

Biocatalysis and Biotransformation

Volumn 25, Issue 5, 2007, Pages 401-407

  Mazier, Claire ^a   Lombard, Murielle ^a   Sari, Marie Agnes ^a   Buisson, Didier ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Fexofenadine; Hydroxylation; Oxygenase

Indexed keywords

FEXOFENADINE; METABOLITE FORMATION; OXYGENASE; STREPTOMYCES PLATENSIS; TERFENADINE;

HYDROXYLATION; METABOLITES; OXIDATION; PLANT CELL CULTURE;

BIOCHEMISTRY;

ANTIHISTAMINIC AGENT; DRUG METABOLITE; FEXOFENADINE; HYDROXYTERFENADINE; PEPTONE; TERFENADINE; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CELL AGING; CONTROLLED STUDY; CULTURE MEDIUM; DRUG HYDROXYLATION; DRUG OXIDATION; DRUG SYNTHESIS; NONHUMAN; PH; SOYBEAN; STREPTOMYCES; STREPTOMYCES PLATENSIS;

GLYCINE MAX; STREPTOMYCES PLATENSIS;

EID: 35148834294     PISSN: 10242422     EISSN: 10292446     Source Type: Journal    
DOI: 10.1080/10242420701510601     Document Type: Article

References (27)

1. Azerad, R. (1999) Microbial models for drug metabolism. Adv Biochem Eng Biotechnol, 63, pp. 169-218.
2. Azerad, R., Biton, J. and Lacroix, I. (1999) Nouveau procédé de prẃparation de la fexofénadine.
3. Giacomo, B Di, Coletta, D., Natalini, B., Ni, M-H and Pellicciari, R. (1999) A new synthesis of carboxyterfenadine (fexofenadine) and its bioisosteric tetrazole analogs. IL Farmaco, 54, pp. 600-610.
4. Fang, QK, Senanayake, CH, Wilkinson, HS and Wald, SA (1998) An efficient and facile synthesis of racemic and optically active fexofenadine. Tetrahedr Letts, 39, pp. 2701-2704.
5. Guengerich, FP (2001) Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol, 14:6, pp. 611-650.
6. Jezquel, SG (1998) Microbial models of mammalian metabolism: Uses and misuses (clarification of some misconceptions). J Mol Cat B: Enzym, 5, pp. 371-377.
7. Jurima-Romet, M., Crawford, K., Cyr, T. and Inaba, T. (1994) Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals. Drug Metab Dispos, 22:6, pp. 849-857.
8. Kawai, SH, Hambalek, RJ and Just, G. (1994) A facile synthesis of an oxidation product of terfenadine. J Org Chem, 59, pp. 2620-2622.
9. Markham, A. and Wagstaff, A. (1998) Fexofenadine. Drugs, 55:2, pp. 269-274.
10. Mazier, C., Jaouen, M., Sari, M-A and Buisson, D. (2004) Microbial oxidation of terfenadine and ebastine into fexofenadine and carebastine. Bioorg Med Chem Letts, 14:21, pp. 5423-5426.
11. Meiwes, J. and Worm, M. (1998) Process for the preparation of 4-(4-(4-(hydroxybiphenyl)-1-piperidinyl)-1 -hydroxybutyl)-α,α-dimethylphenyl-acetic acid and phosphorylated derivatives.
12. Michels, PC and Zirbes, EL. (2002) Process for the production of piperidine derivatives with microorganisms.
13. Monahan, BP, Ferguson, CL, Killeavy, ES, Lloyd, BK, Troy, J. and Cantilena, LRJ (1991) Torsades de pointes occurring in association with terfenadine use. JAMA, 266, pp. 2375-2376.
14. Pacey, MS. (2003)
15. Patel, S., Waykole, L., Repic, O. and Chen, K-M (1996) Synthesis of terfenadine carboxylate. Synth Commun, 26:24, pp. 4699-4710.
16. Pohjola-Sintonen, S., Viitasalo, M. and Toivonen, L. (1993) Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia. Eur J Clin Pharmacol, 45, pp. 191-193.
17. Rafferty, P. and Holgate, ST (1987) Terfenadine (Seldane) is a potent and selective histamine H1 receptor antagonist in asthmatic airways. Am Rev Respir Dis, 135:1, pp. 181-184.
18. Renwick, AG (1999) The metabolism of antihistamines and drug interactions: The role of cytochrome P450 enzymes. Clin Exp Allergy: J Br Soc Allergy Clin Immunol, 29, pp. 116-124.
19. Sariaslani, FS and Kunz, DA (1986) Induction of cytochrome P-450 in Streptomyces griseus by soybean flour. Biochem Biophys Res Commun, 141:2, pp. 405-410.
20. Schmitz, G., Franke, D., Stevens, S., Takors, R., Weuster-Botz, D. and Wandrey, C. (2000) Regioselective oxidation of terfenadine with Cunninghamella blakesleena. J Mol Cat B: Enzym, 10, pp. 313-324.
21. Schwartz, H. and Böttcher, H. (1993) Process for the preparation of carebastine and similar materials.
22. Schwartz, H., Licht, RE and Radunz, HE (1993) Microbial metabolism of the beta-adrenoreceptor antagonist Bisoprolol. Appl Microbiol Biotechnol, 40:2, pp. 382-385.
23. Schwartz, H., Liebig-Weber, A., Hochstätter, H. and Böttcher, H. (1996) Microbial oxidation of ebastine. Appl Microbiol Biotechnol, 44, pp. 731-735.
24. Simpson, K. and Jarvis, B. (2000) Fexofenadine: A review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. Drugs, 59:2, pp. 301-321.
25. Smith, RV and Rosazza, JP (1975) Microbial models of mammalian metabolism. J Pharm Sci, 64:11, pp. 1737-1759.
26. Smith, RV and Rosazza, JP (1975) Microbial systems for study of the biotransformations of drugs. Biotechnol Bioeng, pp. 785-814.
27. Trower, MK, Sariaslani, FS and O'Keefe, DP (1989) Purification and characterization of a soybean flour-induced cytochrome P-450 from Streptomyces griseus. J Bacteriol, 171:4, pp. 1781-1787.